19.60USD+1.40%Mkt Cap: 1.65B USDP/E: —Last update: 2026-06-01
Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutical…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.65B USD
Enterprise Value1.04B USD
Revenue (TTM)42.95M USD
Gross Profit-102.46M USD
Net Income (TTM)-38.63M USD
Revenue/Share0.4910 USD
Last Price19.60 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees187
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-10.86
PEG—
EV/EBITDA-7.42
EV/Revenue24.16
P/S38.77
P/B3.18
EPS (TTM)-1.48
EPS (Forward)-1.81
52W Range
3.90072% of range25.77
52W High25.77 USD
52W Low3.900 USD
Profitability
Gross Margin-238.54%
Oper. Margin-1188.46%
EBITDA Margin0.00%
Profit Margin-31.23%
ROE-16.57%
ROA-8.61%
Growth
Revenue Growth-95.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-22.80M USD
CapEx (TTM)4.70M USD
FCF Margin-179.64%
FCF Yield-4.68%
Net Debt-627.16M USD
Net Debt/EBITDA4.48
Balance Sheet
Debt/Equity0.17
Current Ratio9.54
Quick Ratio9.44
Book Value/Sh6.190 USD
Cash/Share7.886 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)32.33 USD
Target Range29.00 USD – 37.00 USD
# Analysts6
Ownership
Shares Out.84.48M
Float52.99M
Insiders0.59%
Institutions113.10%
Short Interest
Short Ratio18.7d
Short % Float17.99%
Short % Out.17.71%
Shares Short14.96M
Short (prev mo.)15.84M
Technical
SMA 5018.17 (+7.9%)
SMA 20014.85 (+31.9%)
Beta1.62
S&P 52W Chg27.94%
Avg Vol (30d)712.85K
Avg Vol (10d)776.90K
Technical Indicators
RSI (14)54.1
MACD0.0995
MACD Signal0.0915
MACD Hist.+0.0080
BB Upper20.45 USD
BB Middle19.07 USD
BB Lower17.69 USD
BB Width14.48%
ATR (14)1.032 USD
Vol Ratio (20d)0.52x